Danil Dmitrievich Prokhorov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Danil Dmitrievich Prokhorov has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Evgeniy Aleksandrovich Toneev
Regional Clinical Oncology Dispensary; Ulyanovsk State University
9 shared publications - Aleksandr Aleksandrovich Martynov
Ulyanovsk Regional Oncology Center
4 shared publications - S. A. Simatov
State Budgetary Healthcare Institution of the Samara Region «Tolyatti City Clinical Hospital No. 5»; Federal State Budgetary Educational Institution of Higher Education «Samara State Medical University» of the Ministry of Health of the Russian Federation
3 shared publications - Наталья Владимировна Деньгина
Государственное учреждение здравоохранения «Областной клинический онкологический диспансер» Министерства здравоохранения Российской Федерации, г. Ульяновск, Российская Федерация
3 shared publications - A. V. Galchin
Ulyanovsk Regional Oncology Center
2 shared publications - Baymurat Musaevich Asanov
Ulyanovsk State University
2 shared publications
Latest Publications
- 27 October 2026
- Published by PANORAMA Publishing House in Hirurg (Surgeon)
- No. 5,p. 78-87
Ileotransverse anastomotic insufficiency after right hemicolectomy: the role of anastomosis technique, comorbidity, and intraoperative blood loss
Ileotransverse anastomotic insufficiency after right hemicolectomy remains a clinically significant complication, whereas the independent role of handsewn and stapled anastomosis should be assessed together with baseline patient risk and intraoperative conditions. The aim of this study was to evaluate surgical outcomes after right hemicolectomy according to the anastomosis technique and to identif y factors associated with anastomotic insufficiency. A single-center retrospective cohort study included 289 patients: 132 underwent stapled anastomosis and 157 underwent handsewn anastomosis. The primary endpoint was ileotransverse anastomotic insufficiency. Anastomotic insufficiency occurred in 11/132 (8.3 %) patients after stapled anastomosis and in 8/157 (5.1 %) after handsewn anastomosis (p=0.342). Stapled anastomosis was associated with shorter operative time, 151.5 [133.8; 176.2] versus 172.0 [147.0; 197.0] min (p<0.001), and lower blood loss, 136.5 [101.0; 183.0] versus 191.0 [156.0; 236.0] ml (p<0.001). In multivariable analysis, the anastomosis technique was not an independent predictor of insufficiency (OR 0.39; 95 % CI 0.14–1.09; p=0.074). Independent associations remained for Charlson comorbidity index (OR 1.53; 95 % CI 1.09–2.16; p=0.014) and blood loss per 50 ml (OR 1.50; 95 % CI 1.07–2.11; p=0.020). The findings support a risk-adapted approach to reconstruction after right hemicolectomy.
- 27 October 2026
- Published by PANORAMA Publishing House in Hirurg (Surgeon)
- No. 5,p. 78-87
Ileotransverse anastomotic insufficiency after right hemicolectomy: the role of anastomosis technique, comorbidity, and intraoperative blood loss
Ileotransverse anastomotic insufficiency after right hemicolectomy remains a clinically significant complication, whereas the independent role of handsewn and stapled anastomosis should be assessed together with baseline patient risk and intraoperative conditions. The aim of this study was to evaluate surgical outcomes after right hemicolectomy according to the anastomosis technique and to identif y factors associated with anastomotic insufficiency. A single-center retrospective cohort study included 289 patients: 132 underwent stapled anastomosis and 157 underwent handsewn anastomosis. The primary endpoint was ileotransverse anastomotic insufficiency. Anastomotic insufficiency occurred in 11/132 (8.3 %) patients after stapled anastomosis and in 8/157 (5.1 %) after handsewn anastomosis (p=0.342). Stapled anastomosis was associated with shorter operative time, 151.5 [133.8; 176.2] versus 172.0 [147.0; 197.0] min (p<0.001), and lower blood loss, 136.5 [101.0; 183.0] versus 191.0 [156.0; 236.0] ml (p<0.001). In multivariable analysis, the anastomosis technique was not an independent predictor of insufficiency (OR 0.39; 95 % CI 0.14–1.09; p=0.074). Independent associations remained for Charlson comorbidity index (OR 1.53; 95 % CI 1.09–2.16; p=0.014) and blood loss per 50 ml (OR 1.50; 95 % CI 1.07–2.11; p=0.020). The findings support a risk-adapted approach to reconstruction after right hemicolectomy.
- 27 October 2026
- Published by PANORAMA Publishing House in Hirurg (Surgeon)
- No. 5,p. 66-77
Methods of closing the stump of the gallbladder during reconstructive laparoscopic subtotal cholecystectomy: a comparative study of immediate results
Introduction. Laparoscopic subtotal cholecystectomy is used as a method for safely completing the operation in cases of pronounced inflammatory and anatomical changes in the area of the hepatic‑gallbladder triangle. In the reconstitutive variant of the intervention, the gallbladder stump can be closed with an intracorporeal suture or Roeder’s loops; however, there is insufficient comparative data on the immediate results of these methods. The aim of the study is to compare the immediate results of reconstitutive laparoscopic subtotal cholecystectomy depending on the method used to close the gallbladder stump. Materials and methods. A single-center retrospective study included 85 patients operated on in 2024–2025. The stump was sutured with a continuous in-tracorporeal suture in 41 patients, and Raeder loops were used in 44. The primary endpoint was the Clavien — Dindo grade III — IV complication rate. Additionally, repeated laparoscopy, minimally invasive interventions, bile discharge, postoperative endoscopic retrograde cholangiopancreatography, and the duration of hospitalization were evaluated. Results. The distribution of patients according to the degree of complexity of the Parkland operation differed between the groups (p=0.031), and Raeder loops were more often used for more pronounced local changes. Grade III — IV complications were reported in 3 out of 41 (7.3 %) patients after suturing and in 12 out of 44 (27.3 %) after using Raeder loops (p=0.022; odds ratio 4.75; 95 % confidence interval 1.23–18.32). Additional minimally invasive interventions were required in 1 (2.4 %) and 9 (20.5 %) patients, re-spectively (p=0.015). The frequency of bile leakage, postoperative endoscopic retrograde cholan-giopancreatography, and the duration of hospitalization did not differ. Conclusion. In an uncorrected comparison, stump suturing was associated with a lower incidence of severe complications and additional interventions. However, the higher initial complexity of the operations in the group of Raeder loops does not allow us to interpret the revealed relationship as evidence of the independent advantage of the suture method.
- 27 October 2026
- Published by PANORAMA Publishing House in Hirurg (Surgeon)
- No. 5,p. 66-77
Methods of closing the stump of the gallbladder during reconstructive laparoscopic subtotal cholecystectomy: a comparative study of immediate results
Introduction. Laparoscopic subtotal cholecystectomy is used as a method for safely completing the operation in cases of pronounced inflammatory and anatomical changes in the area of the hepatic‑gallbladder triangle. In the reconstitutive variant of the intervention, the gallbladder stump can be closed with an intracorporeal suture or Roeder’s loops; however, there is insufficient comparative data on the immediate results of these methods. The aim of the study is to compare the immediate results of reconstitutive laparoscopic subtotal cholecystectomy depending on the method used to close the gallbladder stump. Materials and methods. A single-center retrospective study included 85 patients operated on in 2024–2025. The stump was sutured with a continuous in-tracorporeal suture in 41 patients, and Raeder loops were used in 44. The primary endpoint was the Clavien — Dindo grade III — IV complication rate. Additionally, repeated laparoscopy, minimally invasive interventions, bile discharge, postoperative endoscopic retrograde cholangiopancreatography, and the duration of hospitalization were evaluated. Results. The distribution of patients according to the degree of complexity of the Parkland operation differed between the groups (p=0.031), and Raeder loops were more often used for more pronounced local changes. Grade III — IV complications were reported in 3 out of 41 (7.3 %) patients after suturing and in 12 out of 44 (27.3 %) after using Raeder loops (p=0.022; odds ratio 4.75; 95 % confidence interval 1.23–18.32). Additional minimally invasive interventions were required in 1 (2.4 %) and 9 (20.5 %) patients, re-spectively (p=0.015). The frequency of bile leakage, postoperative endoscopic retrograde cholan-giopancreatography, and the duration of hospitalization did not differ. Conclusion. In an uncorrected comparison, stump suturing was associated with a lower incidence of severe complications and additional interventions. However, the higher initial complexity of the operations in the group of Raeder loops does not allow us to interpret the revealed relationship as evidence of the independent advantage of the suture method.
- 24 August 2026
- Published by PANORAMA Publishing House in Hirurg (Surgeon)
- No. 4,p. 151-161
Early biochemical-nutritional model for predicting ileotransverse anastomotic insufficiency after right hemicolectomy: a two-institution retrospective study
Objective. To develop and internally validate an early biochemical-nutritional model for predicting ileotransverse anastomotic insufficiency after right or extended right hemicolectomy. Methods. A two-institution retrospective cohort study was performed. The extended registry included 769 patients with tumors of the cecum, ascending colon, hepatic flexure, and transverse colon who underwent surgery from January 10, 2019 to April 24, 2026. The prediction model was developed in an analytical cohort of 676 patients with available outcome and laboratory data. Results. Anastomotic insufficiency occurred in 41 of 676 patients (6.1 %). Independent factors were postoperative day 1 prognostic nutritional index of 40 or lower (adjusted odds ratio 6.15; 95 % confidence interval 2.19‑17.32; p<0.001), postoperative day 1 neutrophil-to-lymphocyte ratio of 12.11 or higher (3.38; 1.62‑7.07; p=0.001), multiorgan resection (9.00; 3.81‑21.27; p<0.001), and preoperative colostomy (27.23; 6.34‑117.04; p<0.001). The area under the ROC curve of the early model was 0.864; the bootstrap-corrected value was 0.855. A practical score classified patients into low-, intermediate-, and high-risk groups with insufficiency rates of 1.2 %, 8.7 %, and 50.0 %, respectively. Conclusion. Combining postoperative day 1 prognostic nutritional and neutrophil-to-lymphocyte indices with surgical variables identifies patients at high risk of ileotransverse anastomotic insuf ficiency.
- 24 August 2026
- Published by PANORAMA Publishing House in Hirurg (Surgeon)
- No. 4,p. 151-161
Early biochemical-nutritional model for predicting ileotransverse anastomotic insufficiency after right hemicolectomy: a two-institution retrospective study
Objective. To develop and internally validate an early biochemical-nutritional model for predicting ileotransverse anastomotic insufficiency after right or extended right hemicolectomy. Methods. A two-institution retrospective cohort study was performed. The extended registry included 769 patients with tumors of the cecum, ascending colon, hepatic flexure, and transverse colon who underwent surgery from January 10, 2019 to April 24, 2026. The prediction model was developed in an analytical cohort of 676 patients with available outcome and laboratory data. Results. Anastomotic insufficiency occurred in 41 of 676 patients (6.1 %). Independent factors were postoperative day 1 prognostic nutritional index of 40 or lower (adjusted odds ratio 6.15; 95 % confidence interval 2.19‑17.32; p<0.001), postoperative day 1 neutrophil-to-lymphocyte ratio of 12.11 or higher (3.38; 1.62‑7.07; p=0.001), multiorgan resection (9.00; 3.81‑21.27; p<0.001), and preoperative colostomy (27.23; 6.34‑117.04; p<0.001). The area under the ROC curve of the early model was 0.864; the bootstrap-corrected value was 0.855. A practical score classified patients into low-, intermediate-, and high-risk groups with insufficiency rates of 1.2 %, 8.7 %, and 50.0 %, respectively. Conclusion. Combining postoperative day 1 prognostic nutritional and neutrophil-to-lymphocyte indices with surgical variables identifies patients at high risk of ileotransverse anastomotic insuf ficiency.
- 31 March 2026
- Published by Ulyanovsk State University in Ulyanovsk Medico-biological Journal
- No. 1
COMPARATIVE ANALYSIS OF COLON RESECTION RESULTS FOR COLORECTAL CANCER DEPENDING ON THE SIDE OF HEMICOLECTOMY: DATA FROM THE ULYANOVSK REGIONAL CLINICAL DISPENSARY
Colorectal cancer (CRC) is one of the leading causes of cancer morbidity and mortality. In Russia, CRC accounts for approximately 10 % of all cancer cases and ranks third in the structure of cancer-related mortality, highlighting the priority of improving radical surgical treatment. Anastomotic leak (AL) remains a key complication of hemicolectomy for colorectal cancer directly affecting the clinical outcome. Objective. The aim of the study is to conduct a comparative analysis of the incidence of anastomotic leak and the structure of postoperative complications after right and left hemicolectomy in patients with colorectal cancer. Materials and Methods. The retrospective study included 354 patients who underwent surgery at the Ulyanovsk Regional Clinical Oncology Dispensary in 2019-2024. The patients were divided into two groups: those with right hemicolectomy (n=278) and those with left hemicolectomy (n=76). Risk factors for anastomotic leak were analyzed using multivariable logistic regression. Results. According to our data, the frequency of multivisceral resections was comparable between the groups: 8 of 76 cases (10.5 %) for left hemicolectomy and 26 of 278 (9.4 %) for right hemicolectomy. The vast majority of operations in both groups were performed without a multiorgan component: 68 of 76 (89.5 %) and 252 of 278 (90.6 %), respectively. The differences were not statistically significant (χ2, p=0,930). Anastomotic leak was noted in 2.2 % of patients after right hemicolectomy and in 6.6 % after left hemicolectomy (p=0.033). Low preoperative albumin levels (OR 0.84; p=0.023) and the side of surgery (OR 0.30; p=0.033) were identified as independent predictors of the complication. ROC analysis demonstrated high predictive accuracy of the model (AUC=0.879). Conclusion. Right hemicolectomy is characterized by a lower incidence of anastomotic leak compared to left hemicolectomy. A low serum albumin level is a significant predictor of complications. This fact highlights the importance of preoperative assessment and correction of the patient's nutritional status.
- 31 March 2026
- Published by Ulyanovsk State University in Ulyanovsk Medico-biological Journal
- No. 1
COMPARATIVE ANALYSIS OF COLON RESECTION RESULTS FOR COLORECTAL CANCER DEPENDING ON THE SIDE OF HEMICOLECTOMY: DATA FROM THE ULYANOVSK REGIONAL CLINICAL DISPENSARY
Colorectal cancer (CRC) is one of the leading causes of cancer morbidity and mortality. In Russia, CRC accounts for approximately 10 % of all cancer cases and ranks third in the structure of cancer-related mortality, highlighting the priority of improving radical surgical treatment. Anastomotic leak (AL) remains a key complication of hemicolectomy for colorectal cancer directly affecting the clinical outcome. Objective. The aim of the study is to conduct a comparative analysis of the incidence of anastomotic leak and the structure of postoperative complications after right and left hemicolectomy in patients with colorectal cancer. Materials and Methods. The retrospective study included 354 patients who underwent surgery at the Ulyanovsk Regional Clinical Oncology Dispensary in 2019-2024. The patients were divided into two groups: those with right hemicolectomy (n=278) and those with left hemicolectomy (n=76). Risk factors for anastomotic leak were analyzed using multivariable logistic regression. Results. According to our data, the frequency of multivisceral resections was comparable between the groups: 8 of 76 cases (10.5 %) for left hemicolectomy and 26 of 278 (9.4 %) for right hemicolectomy. The vast majority of operations in both groups were performed without a multiorgan component: 68 of 76 (89.5 %) and 252 of 278 (90.6 %), respectively. The differences were not statistically significant (χ2, p=0,930). Anastomotic leak was noted in 2.2 % of patients after right hemicolectomy and in 6.6 % after left hemicolectomy (p=0.033). Low preoperative albumin levels (OR 0.84; p=0.023) and the side of surgery (OR 0.30; p=0.033) were identified as independent predictors of the complication. ROC analysis demonstrated high predictive accuracy of the model (AUC=0.879). Conclusion. Right hemicolectomy is characterized by a lower incidence of anastomotic leak compared to left hemicolectomy. A low serum albumin level is a significant predictor of complications. This fact highlights the importance of preoperative assessment and correction of the patient's nutritional status.
- 31 March 2026
- Published by Ulyanovsk State University in Ulyanovsk Medico-biological Journal
- No. 1
ESOPHAGOJEJUNAL ANASTOMOSIS AFTER TOTAL GASTRECTOMY: TECHNIQUE AND IMMEDIATE RESULTS
Gastric cancer remains a leading cause of cancer-related mortality, and the success of the reconstructive stage in total gastrectomy largely determines the immediate and long-term treatment outcomes. One of the most crucial steps in the procedure is esophagojejunostomy. The incidence of esophagojejunoanal anastomosis leakage reaches 2–10 %, directly correlating with increased mortality rates and diminished quality of life. Despite advancements in mechanical anastomotic techniques, manual methods remain relevant due to better mucosal adaptation and a reduced risk of reflux esophagitis. Objective. The aim of the study is to evaluate the immediate surgical and functional outcomes of the proposed esophagojejunostomy with manual suture after total gastrectomy. Materials and Methods. A single-center retrospective cohort study was conducted involving 74 patients who underwent surgery at the Ulyanovsk Regional Clinical Oncology Dispensary between January 1, 2019, and September 1, 2025. All patients underwent total gastrectomy with D2 lymphadenectomy and Roux-en-Y reconstruction. The esophagojejunoanal anastomosis was formed manually using 3-0 PGA absorbable sutures and an original technique involving suture line invagination. Intraoperative and postoperative parameters, complications according to Clavien-Dindo classification, and functional outcomes (radiological, endoscopic, and scintigraphic data) were evaluated. Results. The average time of esophagojejunostomy was 34.7±7.9 min. The incidence of grade IIIb–V complications according to Clavien-Dindo classification was 6.8 %. Endoscopic follow-up at 6 months revealed signs of esophagitis in 54.1 % of patients, decreasing to 36.5 %, at 12 months; notably, clinically significant forms (LA Grade C–D) were observed only in 4.1 % of cases. Technetium-99m scintigraphy performed in 5 patients revealed no signs of duodenogastroesophageal reflux. No cases of anastomotic leaks were recorded. Conclusion. The proposed esophagojejunostomy with manual suture ensures high integrity, minimizes the risk of anastomotic leakage and reflux esophagitis. Moreover, the method is technically reproducible and cost-effective. The results confirm the reliability and functional viability of the technique in patients undergoing total gastrectomy.
- 31 March 2026
- Published by Ulyanovsk State University in Ulyanovsk Medico-biological Journal
- No. 1
ESOPHAGOJEJUNAL ANASTOMOSIS AFTER TOTAL GASTRECTOMY: TECHNIQUE AND IMMEDIATE RESULTS
Gastric cancer remains a leading cause of cancer-related mortality, and the success of the reconstructive stage in total gastrectomy largely determines the immediate and long-term treatment outcomes. One of the most crucial steps in the procedure is esophagojejunostomy. The incidence of esophagojejunoanal anastomosis leakage reaches 2–10 %, directly correlating with increased mortality rates and diminished quality of life. Despite advancements in mechanical anastomotic techniques, manual methods remain relevant due to better mucosal adaptation and a reduced risk of reflux esophagitis. Objective. The aim of the study is to evaluate the immediate surgical and functional outcomes of the proposed esophagojejunostomy with manual suture after total gastrectomy. Materials and Methods. A single-center retrospective cohort study was conducted involving 74 patients who underwent surgery at the Ulyanovsk Regional Clinical Oncology Dispensary between January 1, 2019, and September 1, 2025. All patients underwent total gastrectomy with D2 lymphadenectomy and Roux-en-Y reconstruction. The esophagojejunoanal anastomosis was formed manually using 3-0 PGA absorbable sutures and an original technique involving suture line invagination. Intraoperative and postoperative parameters, complications according to Clavien-Dindo classification, and functional outcomes (radiological, endoscopic, and scintigraphic data) were evaluated. Results. The average time of esophagojejunostomy was 34.7±7.9 min. The incidence of grade IIIb–V complications according to Clavien-Dindo classification was 6.8 %. Endoscopic follow-up at 6 months revealed signs of esophagitis in 54.1 % of patients, decreasing to 36.5 %, at 12 months; notably, clinically significant forms (LA Grade C–D) were observed only in 4.1 % of cases. Technetium-99m scintigraphy performed in 5 patients revealed no signs of duodenogastroesophageal reflux. No cases of anastomotic leaks were recorded. Conclusion. The proposed esophagojejunostomy with manual suture ensures high integrity, minimizes the risk of anastomotic leakage and reflux esophagitis. Moreover, the method is technically reproducible and cost-effective. The results confirm the reliability and functional viability of the technique in patients undergoing total gastrectomy.
- Open Access
- 13 January 2026
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 24 (6) , 19-30
Non-specific risk factors for predicting intestinal anastomotic leakage following right/left hemicolectomy and sigmoidectomy: development and internal validation of a model
Objective. Тhis study aimed to identify early predictors of intestinal anastomotic leakage following hemicolectomies. Material and Methods . We conducted a retrospective analysis of 583 patients who underwent elective hemicolectomies and sigmoid resections at the Ulyanovsk Regional Oncology Center from 2019 to 2024. Patients with fatal outcomes from comorbid conditions or emergency surgeries were excluded. Complications were assessed using the Clavien-Dindo classification, while tumors were evaluated using the ТNM classification. Statistical analysis involved methods for comparing quantitative and categorical data, assessing odds ratios, and developing a predictive model using logistic regression and ROC analysis. Results. Statistically significant risk factors for intestinal anastomotic leakage were: colostomy before surgery (pConclusion. In our study, the incidence of intestinal anastomotic leakage was 48 (8.24%). Multivariate analysis identified the following statistically significant factors for developing anastomotic leakage: cancer stage, Т-spread of the primary tumor, presence of metastases, operation time, length of hospital stay, preoperative colostomy, multiorgan resection, Clavien–Dindo complications, blood loss volume, type of surgery, albumin levels before surgery, albumin levels on day 1 and day 5 after surgery, neutrophil counts on day 1 and day 5 after surgery, lymphocyte counts on day 1 after surgery, and the neutrophil-to-lymphocyte ratio on day 1 and day 5 after surgery.
- 13 January 2026
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 24 (6) , 19-30
Open AccessNon-specific risk factors for predicting intestinal anastomotic leakage following right/left hemicolectomy and sigmoidectomy: development and internal validation of a model
Objective. Тhis study aimed to identify early predictors of intestinal anastomotic leakage following hemicolectomies. Material and Methods . We conducted a retrospective analysis of 583 patients who underwent elective hemicolectomies and sigmoid resections at the Ulyanovsk Regional Oncology Center from 2019 to 2024. Patients with fatal outcomes from comorbid conditions or emergency surgeries were excluded. Complications were assessed using the Clavien-Dindo classification, while tumors were evaluated using the ТNM classification. Statistical analysis involved methods for comparing quantitative and categorical data, assessing odds ratios, and developing a predictive model using logistic regression and ROC analysis. Results. Statistically significant risk factors for intestinal anastomotic leakage were: colostomy before surgery (pConclusion. In our study, the incidence of intestinal anastomotic leakage was 48 (8.24%). Multivariate analysis identified the following statistically significant factors for developing anastomotic leakage: cancer stage, Т-spread of the primary tumor, presence of metastases, operation time, length of hospital stay, preoperative colostomy, multiorgan resection, Clavien–Dindo complications, blood loss volume, type of surgery, albumin levels before surgery, albumin levels on day 1 and day 5 after surgery, neutrophil counts on day 1 and day 5 after surgery, lymphocyte counts on day 1 after surgery, and the neutrophil-to-lymphocyte ratio on day 1 and day 5 after surgery.
- Open Access
- 4 August 2025
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 24 (3) , 103-113
Results of chemoradiotherapy with CROSS regimen for middle third esophageal cancer
Background. Esophageal cancer (EC) is one of the most aggressive gastrointestinal malignancies with a poor prognosis. The standard treatment for thoracic EC involves chemoradiotherapy (CRT). For localized tumors, a multimodal approach, including neoadjuvant chemoradiotherapy followed by surgery, is considered optimal. This approach can improve long-term treatment outcomes and provide better local control. The CROSS regimen is a commonly used chemoradiotherapy regimen for EC in Europe and Russia.Objective: to evaluate the effectiveness of chemoradiotherapy with the CROSS regimen administered both preoperatively and alone, as well as to assess long-term overall and recurrence-free survival rates.Material and Methods. This retrospective study included patients with stage I–III thoracic esophageal cancer treated at the Ulyanovsk Regional Clinical Oncology Center from January 1, 2019, to December 31, 2023. A total of 94 patients began chemoradiotherapy in the CROSS regimen. The final analysis included 80 (85.1 %) patients who completed the entire treatment program. Data collection was performed according to a unified protocol.Results. The rate of complete pathological response (TRG 1) was 10/26 (38.5 %). The 1-year overall survival rates in patients undergoing surgery and in patients not undergoing surgery were 83.3 % and 71.7 %, respectively. The 3-year overall survival rates in patients undergoing surgery and in patients not undergoing surgery were 58.3 % and 50.9 %, respectively. The 1-year and 3-year recurrence-free survival rates were higher in patients who received CRT followed by surgery compared to those who received CRT alone (76.9 % versus 63.5 % and 53.9 % versus 44.2 %).Conclusion. Chemoradiotherapy with the CROSS regimen was shown to achieve a complete response in more than a third of EC patients. Survival rates were higher in patients undergoing a three-modality approach.
- 4 August 2025
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 24 (3) , 103-113
Open AccessResults of chemoradiotherapy with CROSS regimen for middle third esophageal cancer
Background. Esophageal cancer (EC) is one of the most aggressive gastrointestinal malignancies with a poor prognosis. The standard treatment for thoracic EC involves chemoradiotherapy (CRT). For localized tumors, a multimodal approach, including neoadjuvant chemoradiotherapy followed by surgery, is considered optimal. This approach can improve long-term treatment outcomes and provide better local control. The CROSS regimen is a commonly used chemoradiotherapy regimen for EC in Europe and Russia.Objective: to evaluate the effectiveness of chemoradiotherapy with the CROSS regimen administered both preoperatively and alone, as well as to assess long-term overall and recurrence-free survival rates.Material and Methods. This retrospective study included patients with stage I–III thoracic esophageal cancer treated at the Ulyanovsk Regional Clinical Oncology Center from January 1, 2019, to December 31, 2023. A total of 94 patients began chemoradiotherapy in the CROSS regimen. The final analysis included 80 (85.1 %) patients who completed the entire treatment program. Data collection was performed according to a unified protocol.Results. The rate of complete pathological response (TRG 1) was 10/26 (38.5 %). The 1-year overall survival rates in patients undergoing surgery and in patients not undergoing surgery were 83.3 % and 71.7 %, respectively. The 3-year overall survival rates in patients undergoing surgery and in patients not undergoing surgery were 58.3 % and 50.9 %, respectively. The 1-year and 3-year recurrence-free survival rates were higher in patients who received CRT followed by surgery compared to those who received CRT alone (76.9 % versus 63.5 % and 53.9 % versus 44.2 %).Conclusion. Chemoradiotherapy with the CROSS regimen was shown to achieve a complete response in more than a third of EC patients. Survival rates were higher in patients undergoing a three-modality approach.
- Open Access
- 22 December 2024
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 21,p. 62-69
The experience of using chemoradiotherapy for esophageal cancer with the FOLFOX chemotherapy regimen
Introduction. For an extended period, numerous studies have been conducted to find the optimal treatment regimen for esophageal cancer. Chemoradiotherapy has demonstrated satisfactory results in the treatment of localized and locally advanced forms of this disease. However, the search for the best chemotherapy regimen in combination with radiotherapy remains a current focus of many researchers.Aim. To evaluate the effectiveness and safety of chemoradiotherapy (CRT) using the FOLFOX regimen in patients with esophageal cancer.Materials and methods. A prospective study was conducted at the Ulyanovsk Regional Clinical Oncology Dispensary. The analysis included patients who received chemoradiotherapy with the FOLFOX regimen from December 1, 2022, to March 1, 2024. A total of 19 cases of esophageal cancer treatment at stages I–III were analyzed. Radical surgical treatment was subsequently performed on 5 patients (26.3%). The characteristics of the studied patients were evaluated according to a standardized protocol.Results. In the study group, 18 patients (94.7%) completed the planned course of treatment. One patient received an incomplete course of radiotherapy but completed the entire planned chemotherapy. The most common hematologic complication was leukopenia, observed in 9 patients (47.3%) after the full course of chemoradiotherapy. No cases of febrile neutropenia were reported. The hematologic complications were manageable and did not lead to the discontinuation of treatment. Among non-hematologic complications, the most frequently reported were grade 1–2 nausea in 11 patients (58%) and grade 1–2 vomiting in only 2 cases (10%), which was effectively controlled with antiemetic therapy. Overall and relapse-free survival were assessed. The reason for discontinuing radiotherapy in 1 patient (5.3%) was ulcerative stomatitis. Surgery was performed on 5 patients, with tumor regression (TRG) grades 1–2 according to the Mandard scale observed in 4 of them (80%). One patient (20%) had a TRG 3 response.Conclusions. After chemoradiotherapy with the FOLFOX regime in patients with squamous cell carcinoma of the esophagus, the rate of therapeutic tumor regression (TRG1–2) in operated patients reached 80%. One-year relapse-free survival was 58%, one-year overall survival was 73%, indicating the effectiveness and safety of this chemotherapy regimen as part of the comprehensive treatment of esophageal cancer.
- 22 December 2024
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 21,p. 62-69
Open AccessThe experience of using chemoradiotherapy for esophageal cancer with the FOLFOX chemotherapy regimen
Introduction. For an extended period, numerous studies have been conducted to find the optimal treatment regimen for esophageal cancer. Chemoradiotherapy has demonstrated satisfactory results in the treatment of localized and locally advanced forms of this disease. However, the search for the best chemotherapy regimen in combination with radiotherapy remains a current focus of many researchers.Aim. To evaluate the effectiveness and safety of chemoradiotherapy (CRT) using the FOLFOX regimen in patients with esophageal cancer.Materials and methods. A prospective study was conducted at the Ulyanovsk Regional Clinical Oncology Dispensary. The analysis included patients who received chemoradiotherapy with the FOLFOX regimen from December 1, 2022, to March 1, 2024. A total of 19 cases of esophageal cancer treatment at stages I–III were analyzed. Radical surgical treatment was subsequently performed on 5 patients (26.3%). The characteristics of the studied patients were evaluated according to a standardized protocol.Results. In the study group, 18 patients (94.7%) completed the planned course of treatment. One patient received an incomplete course of radiotherapy but completed the entire planned chemotherapy. The most common hematologic complication was leukopenia, observed in 9 patients (47.3%) after the full course of chemoradiotherapy. No cases of febrile neutropenia were reported. The hematologic complications were manageable and did not lead to the discontinuation of treatment. Among non-hematologic complications, the most frequently reported were grade 1–2 nausea in 11 patients (58%) and grade 1–2 vomiting in only 2 cases (10%), which was effectively controlled with antiemetic therapy. Overall and relapse-free survival were assessed. The reason for discontinuing radiotherapy in 1 patient (5.3%) was ulcerative stomatitis. Surgery was performed on 5 patients, with tumor regression (TRG) grades 1–2 according to the Mandard scale observed in 4 of them (80%). One patient (20%) had a TRG 3 response.Conclusions. After chemoradiotherapy with the FOLFOX regime in patients with squamous cell carcinoma of the esophagus, the rate of therapeutic tumor regression (TRG1–2) in operated patients reached 80%. One-year relapse-free survival was 58%, one-year overall survival was 73%, indicating the effectiveness and safety of this chemotherapy regimen as part of the comprehensive treatment of esophageal cancer.
- Open Access
- 15 November 2023
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 22 (5) , 84-95
Results of combined and chemoradiation treatment of patients with thoracic esophageal cancer according to the data of the regional cancer center
Background. esophageal cancer (ec) is one of the most aggressive malignancies of the gastrointestinal tract. chemoradiation therapy is the standard of care for locally advanced ec.The purpose of the study was to evaluate the efficacy of chemoradiation therapy given alone and in combination with surgery in patients with thoracic esophageal cancer.Material and Methods. From January 1, 2012 to december 31, 2021, a total of 940 patients with thoracic esophageal cancer were registered in the regional cancer registry, of which 178 patients were selected for concurrent chemoradiotherapy (CRT) at clinical stages I–III. thirty seven thoracic esophageal cancer patients who received CRT and required treatment interruption due to complications were not included in our analysis. The final analysis included 141 patients.Results. 37 (20.7 %) patients were unable to complete treatment due to intolerance and the development of severe complications of CRT. Hematological toxicity of grade 3-4 was noted in 21 patients (14.8 %). Non-hematological complications of grade 2-4 were noted in 109 patients (77.3 %). The 5-year relapse-free survival rates in patients undergoing and non-undergoing to surgery were 23.0 and 25.0 %, respectively (p=0.018). Overall 5-year survival rates were 24 and 27 %, respectively (p=0.020). The rate of pathological complete response (pcR) was 43.5 % (in 20 of 46 patients who underwent surgery after CRT). The median survival time in patients with clinical complete response (ccR) was 24.0 months and the median survival time in patients with pcR was 29.0 months. The 3-year survival rates were 21 and 45 %, respectively (p=0.050).Conclusion. The combination of chemoradiotherapy and surgery in patients with thoracic esophageal cancer demonstrated an increase in overall survival in our study. if there is a complete clinical response to CRT and contraindications for surgery or the patient’s refusal to undergo surgery, it is advisable to use the “wait & watch” tactic.
- 15 November 2023
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 22 (5) , 84-95
Open AccessResults of combined and chemoradiation treatment of patients with thoracic esophageal cancer according to the data of the regional cancer center
Background. esophageal cancer (ec) is one of the most aggressive malignancies of the gastrointestinal tract. chemoradiation therapy is the standard of care for locally advanced ec.The purpose of the study was to evaluate the efficacy of chemoradiation therapy given alone and in combination with surgery in patients with thoracic esophageal cancer.Material and Methods. From January 1, 2012 to december 31, 2021, a total of 940 patients with thoracic esophageal cancer were registered in the regional cancer registry, of which 178 patients were selected for concurrent chemoradiotherapy (CRT) at clinical stages I–III. thirty seven thoracic esophageal cancer patients who received CRT and required treatment interruption due to complications were not included in our analysis. The final analysis included 141 patients.Results. 37 (20.7 %) patients were unable to complete treatment due to intolerance and the development of severe complications of CRT. Hematological toxicity of grade 3-4 was noted in 21 patients (14.8 %). Non-hematological complications of grade 2-4 were noted in 109 patients (77.3 %). The 5-year relapse-free survival rates in patients undergoing and non-undergoing to surgery were 23.0 and 25.0 %, respectively (p=0.018). Overall 5-year survival rates were 24 and 27 %, respectively (p=0.020). The rate of pathological complete response (pcR) was 43.5 % (in 20 of 46 patients who underwent surgery after CRT). The median survival time in patients with clinical complete response (ccR) was 24.0 months and the median survival time in patients with pcR was 29.0 months. The 3-year survival rates were 21 and 45 %, respectively (p=0.050).Conclusion. The combination of chemoradiotherapy and surgery in patients with thoracic esophageal cancer demonstrated an increase in overall survival in our study. if there is a complete clinical response to CRT and contraindications for surgery or the patient’s refusal to undergo surgery, it is advisable to use the “wait & watch” tactic.